Skip to content
Home/GPs/Vivalto Partners
Vivalto Partners

Vivalto Partners

Paris, France·Founded 2020··vivaltopartners.com

Vivalto Partners is an independent European private equity management company founded in 2021 and based in Paris, specializing in investments in profitable small and mid-sized companies within the healthcare sector across France and continental Europe. It manages a healthcare-focused fund, Vivalto Capital I, with a target size of around €700 million, supporting companies through capital and strategic and operational assistance.

AUM
€700M
Funds
1
vintages 2024
Portfolio
7
Exits
0
SectorsHealthcareBusiness Services

Key facts

HQParis, France
Founded2020

Recent exits

No exits recorded yet.

Coverage notes

1 fund tracked, 7 portfolio companies (7 active · 0 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Vivalto Partners has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
Vivalto Partners Fund IGrowth
2024 · 2yr€700M7 active

Unrealized

7 held
HealthcareFrance· Entry 2024
HealthcareFrance· Entry 2023
Linnea SAActive
HealthcareSwitzerland· Entry 2025
HealthcareFrance· Entry 2022
HealthcareFrance· Entry 2025
HealthcareFrance· Entry 2019
HealthcareFrance· Entry 2021
Track Vivalto Partners

Saved GPs appear in your watchlist, one click from your workspace.

About Vivalto Partners

Vivalto Partners is an independent European private equity management company with €700 million of assets under management as of December 2024, founded in 2021 and headquartered in Paris. The firm specialises in investments in profitable small and mid-sized companies within the healthcare sector, with the healthcare-exclusive focus distinguishing Vivalto from generalist mid-cap peers and aligning the platform with the structural growth trends in European healthcare.

Investment thesis

Vivalto targets European small and mid-cap healthcare companies, deploying equity tickets typically ranging from €15 million to €60 million per transaction across both majority and significant minority positions. Sector focus spans the breadth of healthcare verticals including pharma services, medical devices, healthcare services, digital health and selectively biotech businesses. The exclusive healthcare mandate enables deep clinical, regulatory and operational expertise across portfolio companies.

Recent activity

The platform tracks a single dedicated fund vehicle and 7 active portfolio companies across the inaugural deployment of the healthcare-focused PE programme. As a recently established platform (2021 founding), Vivalto is in the active deployment phase with realised exits expected in subsequent years aligned with typical 5-7 year buyout cycles. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated May 2026 · Sourced from public filings